| |
| |
|
| Insider
Information: |
Nagendran Sukumar |
| Relationship: |
President and Head of ... |
| City: |
Bannockburn |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
932,101 |
|
|
Indirect Shares
|
20,000 |
|
|
| Direct
Value |
$346,006 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
952,101 |
|
|
| Total
Value |
$346,006 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avexis, Inc. |
AVXS |
Sr. VP & Chief Medical... |
2018-05-15 |
0 |
2017-04-03 |
0 |
Premium* |
|
|
Immunovant Inc |
IMVT |
Director |
|
0 |
2019-05-09 |
20,000 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
Director |
2019-07-25 |
34,258 |
2019-07-25 |
0 |
Premium* |
|
|
Taysha Gene Therapies, Inc. |
TSHA |
President and Head of ... |
2024-01-02 |
897,843 |
2020-09-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TSHA |
Taysha Gene Therapies, In... |
President and Head of R&D |
• • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
863,617 |
897,843 |
0 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
President and Head of R&D |
• • – |
2023-05-16 |
4 |
B |
$0.68 |
$3,400 |
D/D |
5,000 |
34,226 |
2.73 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
Director |
– • – |
2022-02-02 |
4 |
B |
$8.01 |
$80,100 |
D/D |
10,000 |
29,226 |
2.39 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
Director |
– • – |
2020-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
19,226 |
19,226 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • – |
2019-07-25 |
4 |
A |
$4.65 |
$150,000 |
D/D |
32,258 |
34,258 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Director |
– • – |
2019-05-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
20,000 |
|
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2018-05-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,800) |
0 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2018-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,800 |
3,800 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2018-03-01 |
4 |
AS |
$121.51 |
$224,618 |
D/D |
(1,780) |
0 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2018-03-01 |
4 |
OE |
$18.47 |
$32,877 |
D/D |
1,780 |
1,780 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2018-02-01 |
4 |
AS |
$117.12 |
$209,969 |
D/D |
(1,780) |
0 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2018-02-01 |
4 |
OE |
$18.47 |
$32,877 |
D/D |
1,780 |
1,780 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2018-01-02 |
4 |
AS |
$109.42 |
$195,308 |
D/D |
(1,780) |
0 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2018-01-02 |
4 |
OE |
$18.47 |
$32,877 |
D/D |
1,780 |
1,780 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2017-12-01 |
4 |
AS |
$93.72 |
$168,696 |
D/D |
(1,780) |
0 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2017-12-01 |
4 |
OE |
$18.47 |
$32,877 |
D/D |
1,780 |
1,780 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2017-11-01 |
4 |
AS |
$98.51 |
$180,244 |
D/D |
(1,780) |
0 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2017-11-01 |
4 |
OE |
$18.47 |
$32,877 |
D/D |
1,780 |
1,780 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2017-10-02 |
4 |
AS |
$96.05 |
$173,108 |
D/D |
(1,780) |
0 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2017-10-02 |
4 |
OE |
$18.47 |
$32,877 |
D/D |
1,780 |
1,780 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2017-09-01 |
4 |
AS |
$92.93 |
$165,978 |
D/D |
(1,780) |
0 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2017-09-01 |
4 |
OE |
$18.47 |
$32,877 |
D/D |
1,780 |
1,780 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2017-08-01 |
4 |
OE |
$18.47 |
$32,877 |
D/D |
1,780 |
1,780 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2017-08-01 |
4 |
AS |
$91.24 |
$162,906 |
D/D |
(1,780) |
0 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Sr. VP & Chief Medical Officer |
• – – |
2017-06-01 |
4 |
AS |
$70.20 |
$126,214 |
D/D |
(1,780) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
